You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 250 No. 17, November 4, 1983 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (88)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Posttransfusion Hepatitis Type A

F. Blaine Hollinger, MD; Narayan C. Khan, PhD; Paul E. Oefinger, PhD; David H. Yawn, MD; A. Carl Schmulen, MD; Gordon R. Dreesman, PhD; Joseph L. Melnick, PhD

JAMA. 1983;250(17):2313-2317.


Abstract

Hepatitis A virus (HAV) transmission through blood is a rare but potential cause of posttransfusion hepatitis. We can now document such a case supported by laboratory evidence of HAV in the donor blood. A 10-year-old girl manifested icteric hepatitis A 31 days after receiving a single unit of packed RBCs from a donor who subsequently experienced hepatitis A and died in hepatic failure. Hepatitis A virus antigen was detected in the donor's hepatocytes and in plasma obtained from the original donor unit. The density in cesium chloride of the HAV antigenic activity from the liver and plasma ranged from 1.33 to 1.37 g/cu cm, which is similar to that reported for infectious HAV particles. The implicated donor plasma had normal aminotransferase levels and was negative for antibody to HAV. Inoculation of this plasma into a chimpanzee resulted in the development of hepatitis A 23 days later based on the appearance of fecal HAV antigen, hepatitis, and IgM anti-HAV seroconversion. These data clearly document the presence of HAV in the donor sample that produced posttransfusion hepatitis A.

(JAMA 1983;250:2313-2317)



Author Affiliations

From the Departments of Virology and Epidemiology (Drs Hollinger, Khan, Oefinger, Dreesman, and Melnick), Medicine (Dr Schmulen), and Pathology (Dr Yawn), Baylor College of Medicine, Houston.


Footnotes

Reprint requests to Department of Virology and Epidemiology, Baylor College of Medicine, Houston, TX 77030 (Dr Hollinger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fulminant Hepatitis A in Intravenous Drug Users with Chronic Liver Disease
Akriviadis and Redeker
ANN INTERN MED 1989;110:838-839.
ABSTRACT  

Transfusion-Acquired Hepatitis A in a Premature Infant With Secondary Nosocomial Spread in an Intensive Care Nursery
Azimi et al.
Arch Pediatr Adolesc Med 1986;140:23-27.
ABSTRACT  

Nosocomial Hepatitis A
GOODMAN
ANN INTERN MED 1985;103:452-454.
ABSTRACT  

Avoiding Infection From Blood Transfusion in Neonatal Units
Novak
JAMA 1985;253:2361-2362.
ABSTRACT  

Posttransfusion Hepatitis A in a Neonatal Intensive Care Unit
Noble et al.
JAMA 1984;252:2711-2715.
ABSTRACT  

Hepatitis A in Neonatal Care Units: Not Rare Enough?
Grady
JAMA 1984;252:2755-2755.
ABSTRACT  

Transmission of Hepatitis A by Transfusion of Blood Products
Sherertz et al.
Arch Intern Med 1984;144:1579-1580.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.